Nexthera Capital »

Intra Cellular Therapies shares owned by Nexthera Capital

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Nexthera Capital from 13F filings

Historical chart of Nexthera Capital investment in Intra Cellular Therapies

23:59:59.999Jun 29, 201923:59:59.999500:00:00Jun 30, 201900:00:00.000500:00:00.0011.86477M1.8647705M1.864771M1.8647715M1.864772M143.664k143.6645k143.665k143.6655k143.666k
Value ($)Share countHistorical ITCI position of Nexthera Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Nexthera Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Nexthera Capital

Quarter filed Position value Share count Share price at filing
2019-06-30 $1.9M 144k 12.98

More positions owned by Nexthera Capital

Intercept Pharmaceuticals In
Insmed (INSM)
Audentes Therapeutics
Neurocrine Biosciences (NBIX)
Sarepta Therapeutics (SRPT)
Global Blood Therapeutics In
Immunomedics
Coherus Biosciences (CHRS)
Ascendis Pharma A S (ASND)
Pacira Pharmaceuticals (PCRX)
Urogen Pharma (URGN)
Uniqure Nv (QURE)
Amarin Corporation (AMRN)
Abbvie (ABBV)
Biohaven Pharmaceutical Holding

View all positions for Nexthera Capital

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Norges Bank Investment Management
Invesco
venBio Select Advisor
Bellevue Group
Deep Track Capital
State Street Corporation
Franklin Resources
Geode Capital Management
ClearBridge Advisors
Pictet Asset Management Holding SA

View all funds holding Intra Cellular Therapies